Palvella Therapeutics
Price & Volume
Stats
See more52W Range | $18.22-$151.18 |
Market Cap | $1.7B |
Shares Short | 1M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$2.91 |
News
See moreYahoo Finance • 5 days ago
Palvella Therapeutics Strengthens Leadership Team with Appointment of Rare Disease Commercial Leader Jennifer J. McDonough as Senior Vice President of Market Access and Patient Services
Yahoo Finance • 12 days ago
Palvella Therapeutics Announces Issuance of European Patent Covering Anhydrous Compositions of Rapamycin
Yahoo Finance • 30 days ago
Palvella Prices $200 Mln Upsized Offering To Advance Late-Stage QTORIN Pipeline
Yahoo Finance • 30 days ago
Palvella Therapeutics Announces Pricing of Upsized Public Offering
About
CEO | Mr. Wesley H. Kaupinen |
CFO | Mr. Matthew E. Korenberg |
Address | 125 Strafford Avenue, Wayne, PA, United States, 19087 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 14 |
